BPMC | Blueprint Medicines Corp
Category: Consumer goods
Quick infos Headquarters: Massachusetts, United States Trade prices Volume: Market Cap: 4.93B Prev closed: 75.26 Open: 74.64 High: 75.42 Low: 73.72 52 week low: 43.29 52 week high: 87.43 Dividends: No Dividends Next ER: July 29, 2021 Before Market Opens
Company Profile We are working to advance a deep pipeline of precision therapies, designed to allow patients to live longer, healthier lives. Our approach combines our leading expertise in protein kinases with sound execution and an intense focus on discovery.
We maintain a diverse and growing portfolio of research programs, moving multiple investigational medicines through clinical development for patients with a broad range of genomically defined cancers and rare diseases.
Earnings History Date EPS / Forecast Revenue / Forecast July 29, 2021 -1.86 / -1.8527.3M / 23.02MBeat! April 29, 2021 -1.72 / -1.8921.58M / 17.06MBeat! February 17, 2021 -1.53 / -1.634.11M / 30.75MBeat! October 29, 2020 11.16 / 6.87745.12M / 627.42MBeat! July 30, 2020 -2.28 / -2.148.34M / 7.17MBeat! view more
Historical Data Date Price Open High Low Vol Change ER Sep 17, 2021 106.00 103.64 106.22
102.52
818.57K 2.95% Sep 16, 2021 102.96 103.97 103.97
101.18
466.90K -0.74% Sep 15, 2021 103.73 100.54 103.84
99.20
388.44K 3.70% Sep 14, 2021 100.03 99.96 101.25
98.83
270.57K 0.52% Sep 13, 2021 99.51 98.70 101.76
97.46
583.96K 0.83% Sep 10, 2021 98.69 94.46 98.97
93.28
445.12K 4.51% Sep 9, 2021 94.43 95.21 96.56
94.10
281.02K -0.91% Sep 8, 2021 95.30 95.31 96.70
93.82
278.32K -0.42% Sep 7, 2021 95.70 97.35 98.48
95.08
231.87K -2.16% Sep 3, 2021 97.81 98.21 99.23
97.58
413.93K -0.8% view more
NASDAQ - Nasdaq Stock Market
More profiles and info about the company Founded:2008 Employees:394 News
Blueprint Medicines Corporation (NASDAQ:BPMC) Just Beat EPS By 19%: Here's What Analysts Are Forecasting For Next Year finance.yahoo.com Nov 1, 2020 7:43 am
Blueprint Medicines: Q3 Earnings Insights finance.yahoo.com Oct 30, 2020 7:38 am Blueprint Medicines EPS beats by $1.80, beats on revenue seekingalpha.com Oct 29, 2020 7:07 pm
Blueprint Medicines to Present at 18th Annual Morgan Stanley Global Healthcare Conference finance.yahoo.com Oct 29, 2020 4:01 pm Blueprint Medicines Inks Deal With Roche Worth Up to $1.7 Billion fool.com Oct 29, 2020 12:23 pm
Blueprint Medicines (BPMC) Q3 Earnings Beat, Revenues Rise Y/Y finance.yahoo.com Oct 29, 2020 11:17 am Blueprint Medicines shares gain on deal with Roche marketwatch.com Oct 29, 2020 8:28 am Blueprint Medicines Q3 Earnings Preview seekingalpha.com Oct 29, 2020 1:49 am Blueprint's avapritinib OK'd in Europe for type of GI tract cancer seekingalpha.com Sep 26, 2020 12:19 am
Blueprint Medicines Reports Positive Test Results For Rare Disease Treatment; BPMC Stock Jumps investors.com Sep 22, 2020 4:23 pm
Company News for Sep 23, 2020 finance.yahoo.com Oct 29, 2020 9:30 am
Blueprint Medicines (BPMC) Q3 Earnings and Revenues Surpass Estimates finance.yahoo.com Oct 29, 2020 8:35 am
The Daily Biotech Pulse: Coronavirus Vaccine Updates From J&J & MediciNova, Australian Regulatory Nod For GW Pharma finance.yahoo.com Oct 29, 2020 8:05 am
Blueprint Medicines Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) finance.yahoo.com Oct 29, 2020 8:00 am
Recap: Blueprint Medicines Q2 Earnings finance.yahoo.com Oct 29, 2020 7:28 am
Blueprint Medicines Reports Second Quarter 2020 Financial Results finance.yahoo.com Oct 29, 2020 7:00 am
Blueprint Medicines Reports Third Quarter 2020 Financial Results finance.yahoo.com Oct 29, 2020 7:00 am
Blueprint Medicines Announces Positive Top-line Results from EXPLORER and PATHFINDER Trials of AYVAKIT (avapritinib) in Patients with Advanced Systemic Mastocytosis finance.yahoo.com Oct 29, 2020 7:00 am
Blueprint Medicines Corp. to Host Earnings Call finance.yahoo.com Oct 29, 2020 6:30 am
We're Not Very Worried About Blueprint Medicines' (NASDAQ:BPMC) Cash Burn Rate finance.yahoo.com Oct 29, 2020 6:23 am This company doesn't provide a dividend.
Talk about Blueprint Medicines Corp below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
ir.blueprintmedicines.com If you are looking for News & events, Press Release, they are available on their Investors Relations site.
Consensus
If you want to help pay for server cost or for improving this tool. You can send it via Paypal .
Buy on Amazon While many books explain the how of bitcoin, The Internet of Money delves into the why of bitcoin. Acclaimed information-security expert and author of Mastering Bitcoin, Andreas M. Antonopoulos examines and contextualizes the significance of bitcoin through a series of essays spanning the exhilarating maturation of this technology.
